Barre verticale Université de Lausanne - Unisciences
 
 
Séparateur Annuaire Séparateur Actualités Séparateur Aide Séparateur Login
Langues:  fr | en
Transparent
RECHERCHE
Transparent
Transparent
Transparent
Photo ambiance
UNIL > Unisciences >
MyUNIL
Transparent
AFFICHER LES DONNEES
Transparent
à
Données actuelles
Transparent

Tatiana Petrova

Coordonnées Enseignements Publications  

Publications

Articles

Ivanov K.I., Agalarov Y., Valmu L., Samuilova O., Liebl J., Houhou N., Maby-El Hajjami H., Norrmén C., Jaquet M., Miura N. et al., Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells. Molecular and Cellular Biology 33(19), pp. 3749-3761, 2013. [DOI] [Web of Science] [Pubmed]

Sabine A., Agalarov Y., Maby-El Hajjami H., Jaquet M., Hägerling R., Pollmann C., Bebber D., Pfenniger A., Miura N., Dormond O. et al., Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Developmental Cell 22(2), pp. 430-445, 2012. [DOI] [Web of Science] [Pubmed]

Jurisic G., Maby-El Hajjami H., Karaman S., Ochsenbein A.M., Alitalo A., Siddiqui S.S., Ochoa Pereira C., Petrova T.V., Detmar M., An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circulation Research 111(4), pp. 426-436, 2012. [DOI] [Web of Science] [Pubmed]

Skog M., Bono P., Lundin M., Lundin J., Louhimo J., Linder N., Petrova T.V., Andersson L.C., Joensuu H., Alitalo K. et al., Expression and prognostic value of transcription factor PROX1 in colorectal cancer. British Journal of Cancer 105(9), pp. 1346-1351, 2011. [DOI] [Web of Science] [Pubmed]

Norrmén C., Vandevelde W., Ny A., Saharinen P., Gentile M., Haraldsen G., Puolakkainen P., Lukanidin E., Dewerchin M., Alitalo K. et al., Liprin (beta)1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity. Blood 115(4), pp. 906-909, 2010. [DOI] [Web of Science] [Pubmed]

Kim H., Nguyen V.P., Petrova T.V., Cruz M., Alitalo K., Dumont D.J., Embryonic vascular endothelial cells are malleable to reprogramming via Prox1 to a lymphatic gene signature. BMC Developmental Biology 10, p. 72, 2010. [DOI] [Web of Science] [Pubmed]

Norrmén C., Ivanov K.I., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., Puolakkainen P., Horsley V., Hu J. et al., FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. Journal of Cell Biology 185(3), pp. 439-457, 2009. [DOI] [Web of Science] [Pubmed]

Thiel A., Ganesan A., Mrena J., Junnila S., Nykänen A., Hemmes A., Tai H.H., Monni O., Kokkola A., Haglund C. et al., 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clinical Cancer Research 15(14), pp. 4572-4580, 2009. [DOI] [Web of Science] [Pubmed]

Mouta-Bellum C., Kirov A., Miceli-Libby L., Mancini M.L., Petrova T.V., Liaw L., Prudovsky I., Thorpe P.E., Miura N., Cantley L.C. et al., Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha. Developmental Dynamics 238(10), pp. 2670-2679, 2009. [DOI] [Web of Science] [Pubmed]

Kirjavainen A., Sulg M., Heyd F., Alitalo K., Ylä-Herttuala S., Möröy T., Petrova T.V., Pirvola U., Prox1 interacts with Atoh1 and Gfi1, and regulates cellular differentiation in the inner ear sensory epithelia. Developmental Biology 322(1), pp. 33-45, 2008. [DOI] [Web of Science] [Pubmed]

Petrova T.V., Bono P., Holnthoner W., Chesnes J., Pytowski B., Sihto H., Laakkonen P., Heikkilä P., Joensuu H., Alitalo K., VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors. Cancer Cell 13(6), pp. 554-556, 2008. [DOI] [Web of Science] [Pubmed] ok

Petrova T.V., Nykänen A., Norrmén C., Ivanov K.I., Andersson L.C., Haglund C., Puolakkainen P., Wempe F., von Melchner H., Gradwohl G. et al., Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 13(5), pp. 407-419, 2008. [DOI] [Web of Science] [Pubmed] ok

Tammela T., Saaristo A., Holopainen T., Lyytikkä J., Kotronen A., Pitkonen M., Abo-Ramadan U., Ylä-Herttuala S., Petrova T.V., Alitalo K., Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nature Medicine 13(12), pp. 1458-1466, 2007. [DOI] [Web of Science] [Pubmed]

Kreuger J., Nilsson I., Kerjaschki D., Petrova T., Alitalo K., Claesson-Welsh L., Early lymph vessel development from embryonic stem cells. Arteriosclerosis, Thrombosis, and Vascular Biology 26(5), pp. 1073-1078, 2006. [DOI] [Web of Science] [Pubmed]

Takemoto M., He L., Norlin J., Patrakka J., Xiao Z., Petrova T., Bondjers C., Asp J., Wallgard E., Sun Y. et al., Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO Journal 25(5), pp. 1160-1174, 2006. [DOI] [Web of Science] [Pubmed]

Baluk P., Tammela T., Ator E., Lyubynska N., Achen M.G., Hicklin D.J., Jeltsch M., Petrova T.V., Pytowski B., Stacker S.A. et al., Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. Journal of Clinical Investigation 115(2), pp. 247-257, 2005. [DOI] [Web of Science] [Pubmed]

Petrova T.V., Karpanen T., Norrmén C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Ylä-Herttuala S. et al., Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nature Medicine 10(9), pp. 974-981, 2004. [DOI] [Web of Science] [Pubmed]

Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H. et al., Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology 5(1), pp. 74-80, 2004. [DOI] [Web of Science] [Pubmed]

Kerjaschki D., Regele H.M., Moosberger I., Nagy-Bojarski K., Watschinger B., Soleiman A., Birner P., Krieger S., Hovorka A., Silberhumer G. et al., Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. Journal of the American Society of Nephrology 15(3), pp. 603-612, 2004. [DOI] [Web of Science] [Pubmed]

Veikkola T., Lohela M., Ikenberg K., Mäkinen T., Korff T., Saaristo A., Petrova T., Jeltsch M., Augustin H.G., Alitalo K., Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. FASEB Journal 17(14), pp. 2006-2013, 2003. [DOI] [Web of Science] [Pubmed]

Iljin K., Petrova T.V., Veikkola T., Kumar V., Poutanen M., Alitalo K., A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos. FASEB Journal 16(13), pp. 1764-1774, 2002. [DOI] [Web of Science] [Pubmed]

Petrova T.V., Mäkinen T., Mäkelä T.P., Saarela J., Virtanen I., Ferrell R.E., Finegold D.N., Kerjaschki D., Ylä-Herttuala S., Alitalo K., Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO Journal 21(17), pp. 4593-4599, 2002. [DOI] [Web of Science] [Pubmed]

Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T.V., Kubo H., Thurston G., McDonald D.M., Achen M.G. et al., Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO Journal 20(6), pp. 1223-1231, 2001. [DOI] [Web of Science] [Pubmed]

Baladi S., Tsvetkov P.O., Petrova T.V., Takagi T., Sakamoto H., Lobachov V.M., Makarov A.A., Cox J.A., Folding units in calcium vector protein of amphioxus: Structural and functional properties of its amino- and carboxy-terminal halves. Protein Science 10(4), pp. 771-778, 2001. [DOI] [Web of Science] [Pubmed]

Koppal T., Petrova T.V., Van Eldik L.J., Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells. Brain Research 867(1-2), pp. 115-121, 2000. [DOI] [Web of Science] [Pubmed]

Petrova T.V., Hu J., Van Eldik L.J., Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures. Brain Research 853(1), pp. 74-80, 2000. [DOI] [Web of Science] [Pubmed]

Petrova T.V., Akama K.T., Van Eldik L.J., Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Proceedings of the National Academy of Sciences of the United States of America 96(8), pp. 4668-4673, 1999. [DOI] [Web of Science] [Pubmed]

Mirzoeva S., Koppal T., Petrova T.V., Lukas T.J., Watterson D.M., Van Eldik L.J., Screening in a cell-based assay for inhibitors of microglial nitric oxide production reveals calmodulin-regulated protein kinases as potential drug discovery targets. Brain Research 844(1-2), pp. 126-134, 1999. [DOI] [Web of Science] [Pubmed]

Prêcheur B., Cox J.A., Petrova T., Mispelter J., Craescu C.T., Nereis sarcoplasmic Ca2+-binding protein has a highly unstructured apo state which is switched to the native state upon binding of the first Ca2+ ion. FEBS Letters 395(1), pp. 89-94, 1996. [DOI] [Web of Science] [Pubmed]

Petrova T.V., Takagi T., Cox J.A., Phosphorylation of the IQ domain regulates the interaction between Ca2+-vector protein and its target in Amphioxus. Journal of Biological Chemistry 271(43), pp. 26646-26652, 1996. [Web of Science] [Pubmed]

Petrova T.V., Comte M., Takagi T., Cox J.A., Thermodynamic and molecular properties of the interaction between amphioxus calcium vector protein and its 26 kDa target. Biochemistry 34(1), pp. 312-318, 1995. [DOI] [Web of Science] [Pubmed]

Takagi T., Petrova T., Comte M., Kuster T., Heizmann C.W., Cox J.A., Characterization and primary structure of amphioxus troponin C. European Journal of Biochemistry 221(1), pp. 537-546, 1994. [DOI] [Web of Science] [Pubmed]

Durussel I., Luan-Rilliet Y., Petrova T., Takagi T., Cox J.A., Cation binding and conformation of tryptic fragments of Nereis sarcoplasmic calcium-binding protein: calcium-induced homo- and heterodimerization. Biochemistry 32(9), pp. 2394-2400, 1993. [DOI] [Web of Science] [Pubmed]

Articles - Editoriaux

Alitalo K., Fifteen years of molecular lymphangiogenesis - an interview with Kari Alitalo by Tatiana Petrova. International Journal of Developmental Biology 55(4-5), pp. 389-394, 2011. [DOI] [Web of Science] [Pubmed]

Articles - Synthèses (review)

Sabine A., Petrova T.V., Interplay of mechanotransduction, FOXC2, connexins, and calcineurin signaling in lymphatic valve formation. Advances in Anatomy, Embryology, and Cell Biology 214, pp. 67-80, 2014. [DOI] [Web of Science] [Pubmed]

Norrmén C., Tammela T., Petrova T.V., Alitalo K., Biological basis of therapeutic lymphangiogenesis. Circulation 123(12), pp. 1335-1351, 2011. [DOI] [Web of Science] [Pubmed]

Schulte-Merker S., Sabine A., Petrova T.V., Lymphatic vascular morphogenesis in development, physiology, and disease. Journal of Cell Biology 193(4), pp. 607-618, 2011. [DOI] [Web of Science] [Pubmed]

Maby-El Hajjami H., Petrova T.V., Developmental and pathological lymphangiogenesis: from models to human disease. Histochemistry and Cell Biology 130(6), pp. 1063-1078, 2008. [DOI] [Web of Science] [Pubmed] ok

Mäkinen T., Norrmén C., Petrova T.V., Molecular mechanisms of lymphatic vascular development. Cellular and Molecular Life Sciences 64(15), pp. 1915-1929, 2007. [DOI] [Web of Science] [Pubmed]

Tammela T., Petrova T.V., Alitalo K., Molecular lymphangiogenesis: new players. Trends in Cell Biology 15(8), pp. 434-441, 2005. [DOI] [Web of Science] [Pubmed]

Alitalo K., Tammela T., Petrova T.V., Lymphangiogenesis in development and human disease. Nature 438(7070), pp. 946-953, 2005. [DOI] [Web of Science] [Pubmed]

Saharinen P., Petrova T.V., Molecular regulation of lymphangiogenesis. Annals of the New York Academy of Sciences 1014, pp. 76-87, 2004. [DOI] [Web of Science] [Pubmed]

Karkkainen M.J., Petrova T.V., Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19(49), pp. 5598-5605, 2000. [DOI] [Web of Science] [Pubmed]

Petrova T.V., Makinen T., Alitalo K., Signaling via vascular endothelial growth factor receptors. Experimental Cell Research 253(1), pp. 117-130, 1999. [DOI] [Web of Science] [Pubmed]

Thèses (doctorat)

Ragusa S., Role of transcription factor PROX1 in colon cancer metastasis., Université de Lausanne, Faculté de biologie et médecine, Petrova, T. (dir.), 129 p., 2013.

ok : Revue avec comité de lecture

Transparent     Swiss University
Unicentre  -  CH-1015 Lausanne  -  Suisse  -  Tél. +41 21 692 11 11  -  Fax +41 21 692 20 15